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Aim: To evaluate the effects of Helicobacter pylori on cell proliferation and apoptosis in gastric cancer (GC) both at tumoral and
nontumoral sites and in gastritis.
Materials and methods: Biopsies from 96 patients (gastric cancer = 52, gastritis = 44) were examined immunohistochemically and
histopathologically.
Results: In H. pylori-positive GC patients the average proliferative index (PI) in tumor and nontumor sites was 40.7% and 24.8%, while
in H. pylori-negative patients it was 32.9% and 17.8%, respectively. The PI was significantly higher in the tumor than in the nontumor
sites, regardless of H. pylori infection. Cell proliferation was also significantly associated with intestinal metaplasia in nontumor sections.
The apoptotic index (AI) in H. pylori-positive GC tumor and nontumor sites showed an average of 61.8% and 50.0%, while in H. pylorinegative patients it was 38.1% and 25.0%, respectively. The AI was significantly higher in both groups in the presence of H. pylori. In
gastritis, H. pylori infections lead to a significantly higher PI than AI. H. pylori infection increased the PI and the AI in cases of GC.
Conclusion: H. pylori induced higher proliferative and apoptotic activities in both tumor and nontumor sites of the GC sections, a fact
that provides supportive evidence for its effect.
Key words: Helicobacter pylori, cell proliferation, apoptosis, gastric cancer, gastritis

1. Introduction
Infection of the human gastric mucosa with Helicobacter
pylori generally causes gastritis. In addition, the
organism has been implicated in the development of
other gastrointestinal diseases, such as peptic ulceration,
adenocarcinoma, and mucosa-associated lymphoid tissue
lymphoma (1).
Although the mechanisms causing chronic active
gastritis from other diseases are unclear, various bacterial
factors, as well as the host’s responses, are believed to
contribute to the outcome of infection with H. pylori (2,3).
The development of gastric cancer (GC) is a multistep
process that follows a path of progression from chronic
gastritis, mucosal atrophy, intestinal metaplasia (IM),
dysplasia, and finally cancer (4). H. pylori, which is
considered an oncogenic agent, may influence telomerase
activity, particularly after IM (5).This result supports the
hypothesis that H. pylori may increase the risk of gastric
cancer after IM (5).
H. pylori invades the gastric mucosa and starts
alterations in the normal cell turnover in epithelial
* Correspondence: zgucin@bezmialem.edu.tr

cells. Changes in the activity of apoptosis and/or cell
proliferation ultimately may lead to ulceration or cancer
(6). p53, CD95 (Fas), the Bcl-2 family, and caspases are the
factors involved in the regulation of the balance between
apoptosis and proliferation (7). Apoptosis has an essential
function in maintaining the integrity of the gastrointestinal
mucosa; however, deregulation of this process is associated
with the occurrence of severe lesions (8).
Apoptosis is an important factor that results in cell
death. Caspase 8 activation, oxidative stress, the Bcl-2
family, stress-induced protein genes, transcription factor
p53, neutrophil activation, and TNF-α may be involved in
leading up to apoptosis. Alhan et al. showed an increased
apoptotic index (AI) in experimental acute pancreatitis
in rats, probably due to oxidative stress-related activation
of caspase pathways (9). They did not find any effect of
p53 inactivation therapy during the course of pancreatitis,
which suggested that p53 does not play a role in the
apoptotic mechanism in acute experimental pancreatitis
design (9).
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H. pylori strains bearing the cag pathogenicity island
(PAI), including the cagA gene, have been shown to be
associated with increased gastric inflammation, increased
bacterial load, and both peptic ulcer disease and GC
(2). During infection with cagA-positive–H. pylori,
the bacterium injects its cagA protein into the gastric
epithelial cells, leading to deregulation of the intracellular
signaling pathways (1). According to some previous
studies, the presence or absence of H. pylori infection does
not have an effect on the AI or the degree of atrophy of
the gastric mucosa (10,11). Another report showed that H.
pylori infection may cause a decrease in apoptotic activity
followed by an increase in cell proliferation (8). Eradication
of H. pylori resulted in a significant decrease in gastric
epithelial cell proliferation and apoptosis, indicating an
important role for H. pylori in this process (8).
Ki-67 is a nuclear antigen that has been used as
a proliferating marker that is expressed in all phases
of the cell cycle except G0 (12,13). It is unlikely that
apoptosis involves just a few cells at a specific site of
the tissue examined, which is why it may be found at
different steps of this process (14). It is also detected by
immunohistochemical assays such as caspase and TUNEL
(15,16).
To our knowledge, no previous study has looked in
depth into the proliferative index (PI) and AI of tumor
and nontumor sites of the same resected GC sections.
The objectives of this study were to evaluate the effect of
H. pylori on cell proliferative and apoptotic activities in
tumor and nontumor sites of each resected GC section, to
compare such activities with that of gastritis sections, and
to detect the role of cagA gene and EPIYA motifs in these
processes.
2. Material and methods
2.1. Biopsy samples
Included in this study were 96 patients who attended the
İstanbul Teaching Hospital. There were 52 GC patients,
from whom biopsy samples were obtained during the
period of March 2007 to March 2010. The age range of
these patients was 33–82 years (average: 61), and 12 were
female. From each patient 2 biopsy samples from the
resected GC tissues, 1 from a nontumor site and 1 from
a tumor site (formalin-fixed paraffin-embedded tissues)
were collected. The other 44 were patients with gastritis
from whom antral biopsy samples were collected during
the period of May 2010 to January 2011. The age range
of these patients was 15–84 years (average: 46.4), and
21 were females. Sections were processed and examined
by immunohistochemical analysis and histopathology.
Written consent was obtained from each patient and the
study was approved by the hospital’s ethics committee.
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2.2. DNA isolation and PCR
DNA was extracted with the QIAamp DNA Mini Kit
(QIAGEN, Germany), according to the manufacturer’s
instructions, and stored at –20 °C until used. For the
amplification of cagA gene the following primers were
used: cagA1 (GATAACAGGCAACGTTTTCAGGGA)
and cagA2 (CCGAACGGATCAAAAATTCATGG). The
amplification conditions were 96 °C for 5 min, then 25
cycles of 96 °C for 10 s, 50 °C for 5 s, and 60 °C for 4 min. PCR
products were separated by 2% agarose gel electrophoresis.
The following primers were used to amplify the EPIYA
motif encoding sequences A, B, C, and D, respectively: the
forward primer cagA2, and the reverse primers cagA-P1C
(GTCCTGCTTTCTTTTTATTAACTTKAGC),
cagAP2CG (TTTAGCAACTTGAGCGTAAATGGG), cagAP2TA (TTTAGCAACTTGAGTATAAATGGG), and
cagA-P3E (ATCAATTGTAGCGTAAATGGG) (17).
2.3. Immunohistochemical analysis
2.3.1. Cell proliferation assay (Ki-67 staining)
The Ki-67 staining for detecting cell proliferation in
paraffin-embedded sections of biopsy samples from GC
and gastritis patients was performed using the monoclonal
antibody Clone SP6 (Thermo Scientific, USA). Sections
of 5 µm were cut using a Tissue-Tek Cryo3 Microtome
(Sakura Finetek Inc., USA), then deparaffinized in a hot
air oven at 70 °C. Immunostaining was performed using
the fully automated Leica BOND-MAX instrument (Leica
Microsystems, Germany). Sections were then examined
under the light microscope and positive cells were detected
by brown nuclear staining. The PI in H. pylori-positive
and -negative sections was determined by calculating the
percentage of positive cells in around 500 epithelial cells
observed in 3 randomly selected gastric pit zones.
2.3.2 Apoptosis assays
2.3.2.1. Caspase-3 staining (CPP32 assay)
The detection of apoptotic cells in paraffin-embedded
sections was performed using monoclonal antibody to
CPP32 (ABC Kit, Novocastra, UK). Preparation of sections
and immunostaining were performed as described above
with the automated Leica BOND-MAX instrument (Leica
Microsystems). Sections were then examined under
the light microscope and positive cells were detected by
brown cytoplasmic staining. The AI in H. pylori-positive
and negative sections was calculated as the percentage of
CPP32-positive cells in 500 epithelial cells examined for
each section in 3 randomly selected zones under the light
microscope.
2.3.2.2. TUNEL assay
Apoptotic cells were also detected by TUNEL using
the TACS 2 TdT DAB In Situ Apoptosis Detection Kit
(Trevigen, USA). Immunostaining and the calculation of
AI were done similarly to that for CPP32 and positive cells
(nuclear immunostaining) were recorded.
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2.3.3. Histopathology
Tissue sections obtained from both nontumor and tumor
sites of GC patients and antral biopsies from gastritis
patients were stained with Giemsa and hematoxylin and
eosin (HE) stains. H. pylori status and density, chronic
gastritis (mononuclear cell activity), neutrophil infiltration,
glandular atrophy, and IM were evaluated and graded from
0 to 3 according to the updated Sydney system (18). The
type of GC (intestinal or diffuse) was classified according
to the Lauren classification. The morphological evaluation
of all sections was done by an experienced histopathologist
who was not aware of the section’s origin.

Immunohistochemical analysis of cell proliferation
detected by Ki-67 staining (Figure 1) in H. pylori-positive
GC sections showed that the average PI in tumor and
nontumor sites was 40.7% and 24.8%, respectively, while
in both sites of H. pylori-negative sections it was 32.9% and
17.8%, respectively (Table 1). Correlations between cell
proliferation and the independent variables (H. pylori, sex,
age, IM, atrophy, and tumor type) are shown in Table 2.
The AI in GC sections detected by caspase-3 staining in
H. pylori-positive sections showed that the average results
in tumor and nontumor sites were 61.8% and 50.0%,
respectively, while in H. pylori-negative sections they were
38.1% and 25.0%, respectively (Table 1). Statistical analysis
showed that the AI in GC nontumor and tumor sections
was significantly higher in the presence of H. pylori than
that in the absence of H. pylori (Figure 2). Correlation
between the AI in GC nontumor sites was not significantly
associated with any of the independent variables (H.
pylori, sex, age, IM, atrophy, and tumor type). However, in
tumor sites, a significant association with the independent
variables H. pylori (P = 0.011) and sex (P = 0.047) was
observed (data not shown).
On the other hand, immunohistochemical analysis of
gastric biopsy sections from gastritis patients showed that
the average results of the PI in H. pylori-positive sections
were 54.8% while in H. pylori-negative they were 30.0%
(Table 1). The PI in these sections was significantly higher
in the presence of H. pylori than in the absence of H.
pylori. In these sections cell proliferation was significantly
associated with the independent variables of chronic
inflammation (P = 0.011), neutrophil infiltration (P =
0.000), and increase in H. pylori density (data not shown).
We also found that the PI was significantly higher than
the AI in the presence of H. pylori. The average results of
the AI in H. pylori-positive sections were 36.1% and in
H. pylori-negative were 42.4% (Table 1), and the AI was

2.4. Statistical analysis
The correlation between the dependent variables (cell
proliferation, apoptosis) and the independent variables
(H. pylori, sex, age, IM, atrophy, tumor type) was analyzed
using regression analysis for both GC and gastritis
patients. Differences between cell proliferation and AIs in
the presence or absence of H. pylori were analyzed using
the independent sample t-test. Comparison between GC
nontumor and tumor sites was made by the paired sample
t-test. P < 0.05 was considered as statistically significant.
3. Results
In paraffin-embedded tissue sections, H. pylori was
detected by either staining with Giemsa stain or by PCR.
H. pylori was positive in 35 (67.3%) of 52 samples from
GC patients. The presence of H. pylori in the gastric antral
biopsies was detected either by rapid urease test or PCR.
H. pylori was positive in 31 (70.4%) of 44 gastric biopsies
from gastritis patients. The cagA gene was detected in 15
(48.3%) of 31 H. pylori-positive samples in gastric biopsies.
The EPIYA motifs were of the ABC type in 14 (93.3%)
and ABCC type in 1 (6.7%) of the isolates from gastritis
patients.

Table 1. Average percentages of cell proliferative index (PI) and apoptotic index (AI) detected in paraffin-embedded sections of H.
pylori-negative and -positive biopsy samples from gastric cancer and gastritis patients.
Gastric cancer section
PI
Hp

No.

Hp–

17

Hp+

35

t-test

Gastritis section
AI

PI

NT

T

t-test

NT

T

t-test

No.

17.8%

32.9%

t = 3.66*
SE = 4.14

25.0%

38.1%

t = 2.78*
SE = 4.72

13

24.8%

40.7%

t = 3.23*
SE = 4.92

50.0%

61.8%

t = 1.98
SE = 6.01

31

t = 1.02
t = 1.27
SE = 6.9 SE = 6.14

t = 2.73* t = 3.75*
SE = 8.4 SE = 7.11

AI
t-test

30.0%

42.4%

t = 1.53
SE = 7.96

54.8%

36.1%

t = 3.72*
SE = 5.03

t = 4.12*
SE = 5.96

t = 1.0
SE = 6.24

Hp: H. pylori, NT: nontumor site, T: tumor site.
*: P < 0.05, SE: standard error.
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Table 2. The results of regression analysis showing the relation between Ki-67 staining of
nontumor sites of gastric cancer sections and factors analyzed for the study’s dependent variable:
Ki-67 nontumor sections.
Predictors

Coefficient

Std. error

t

Sig.

45.666

20.009

2.282

0.027

Sex

–0.571

7.586

–0.075

0.94

Age

–0.529

0.29

–1.826

0.074

Hp

6.874

9.233

0.745

0.46

IM

21.963

8.598

2.554

0.014

Atr

–17.488

8.821

–1.983

0.054

Tt

–0.745

10.401

–0.072

0.943

(Constant)

Independent variables: (constant), sex, age, Hp: H. pylori, IM: intestinal metaplasia, Atr: atrophy,
Tt: tumor type.
R2 = 0.207, Durbin–Watson = 1.821, F = 1.962, P = 0.091.

non-tumor site

a

Tumor site

b

Figure 1. a) Immunohistochemical staining for Ki-67 of tumor and nontumor sites of intestinal type gastric cancer section
(H. pylori-positive; magnification of 40×). b) Positive cells were commonly found in the neck region of the gastric pits
(arrows; magnification of 100×).

significantly associated with IM (P = 0.033). The TUNEL
assay was also used to detect the apoptotic activities in
22 gastric biopsy sections from gastritis patients and to
compare the results with those of the caspase-3 staining.
We found that the average results in 17 H. pylori-positive
and 5 H. pylori-negative sections were 23.3% and 19.0%,
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respectively. The PI and AI detected by this assay were
lower than those detected by the caspase-3 assay.
The results of a paired sample t-test revealed statistically
significant differences for PI, which was lower than the
AI in GC tumor and nontumor sites (P = 0.000). We also
found that in the presence of H. pylori, the PI in gastritis
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Figure 2. Immunohistochemical staining for caspase-3 of
nontumor site of H. pylori-positive gastric cancer section. The
cytoplasm of positive cells was stained with brown color (arrows)
(magnification of 100×).

sections was significantly higher than that of GC tumor
and nontumor sites (P = 0.001).
Histopathology evaluation of the tumor type in biopsy
sections from 52 patients with GC showed that of 17 H.
pylori-negative cases, 5 (29.4%) were of the intestinal type
and 12 (70.6%) of the diffuse type. All sections showed
chronic gastritis and, of these, 9 (52.9%) had IM and
glandular atrophy. Biopsy sections from the other 35 H.
pylori-positive patients with GC revealed that 34 (97.2%)
were of the intestinal type and 1 (2.8%) was of the diffuse
type. 3 shows tumor tissue of the intestinal type stained
with HE stain. Chronic gastritis was detected in all
sections, and of these 24 (68.5%) had IM and glandular
atrophy. The type of IM detected in these sections was
of the complete type in 81% of the GC sections. On the
other hand, biopsy sections from 44 patients with gastritis
revealed that of 13 patients with no H. pylori, 84.6% had
chronic inflammation, 38.4% had neutrophil infiltration,
and 3 (23.0%) had IM. Biopsy sections from the other 31
H. pylori-positive patients with gastritis showed 100% with
chronic inflammation, 93.5% with neutrophil infiltration,
and 10 (32.2%) with IM and glandular atrophy.
4. Discussion
The gastric mucosa continuously renews its cells and is
capable of repair after mucosal injury. This is achieved by
sloughing off the damaged cells and rapid migration of
proliferated cells to replace the dead cells. This balance is
maintained by cell proliferation and apoptotic mechanisms.
An imbalance between these 2 mechanisms might lead to
increased cell proliferation and the development of GC
(7,19,20).

Subjects infected with H. pylori, a major etiological
factor of GC reported to be the initial triggering mechanism,
develop chronic active gastritis and subsequently progress
to gastric atrophy and IM, and ultimately to cancer (21).
Previous studies revealed significant difference between
cell proliferation and apoptosis in patients with and
without H. pylori infection. Some studies showed that
H. pylori infection has a relationship with an increased
apoptosis rate in gastric lesions such as chronic gastritis,
GU, IM, and GC (14,22–26). However, some studies
showed that the presence or absence of H. pylori did not
influence the AI (10,11).
Several studies showed contradicting results in regards
to H. pylori infection. No significant difference was found
between the AI of H. pylori-negative normal and H. pyloripositive groups with gastritis and GC (27,28). Leite et al.
(29) also reported no significant difference in AI between
H. pylori-positive and -negative groups with gastritis,
while Tiwari et al. (22) and Shiotani et al. (16) found a
higher AI in H. pylori-positive GC and gastritis groups.
These contradictory results might be due to the presence
or absence of H. pylori virulence factors such as cagPAI,
cagA gene, and EPIYA motifs, which may be responsible
for the differences in apoptotic ratios reported in different
groups of gastritis and GC patients infected with H. pylori.
The CPP32 antibody detects cells undergoing apoptosis
at an early stage, before DNA fragmentation, a late event
in the apoptotic process measured by the TUNEL assay.
This might also be attributed, as suggested earlier, to the
fact that some cells may undergo apoptosis without the
activation of caspase-3 (23,30,31).
In this study, the presence of H. pylori provoked higher
proliferative activities in our GC tumor and nontumor
sections than in the absence of H. pylori. Such activities
were significantly higher in the tumor sections regardless
of the presence or absence of H. pylori. A high PI detected
in the tumor sections in the absence of H. pylori indicates
a biological requirement for the tumor tissue to increase
its proliferative activities. On the other hand, the presence
of H. pylori also induced significantly higher apoptotic
activities in the tumor and nontumor sections in the
absence of H. pylori. Similarly, Shiotani et al. (16) found
that H. pylori infection was associated with increased cell
proliferation and apoptosis in GC patients but not the
controls. However, van der Woude et al. (27), Yoo et al.
(28), and Leite et al. (29) found no significant differences
between the AIs of H. pylori-positive subjects with GC
and H. pylori-negative normal subjects. These findings
do not seem to be clear-cut for the effect of H. pylori on
these activities since many published reports were in
disagreement. Unlike previous reports, we have shown
such an effect in both tumor and nontumor sites of the
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a

b

Figure 3. Intestinal-type gastric cancer section (H. pylori-positive) stained with HE showing invasive tumor cells:
a) magnification of 200×, b) magnification of 400×.

same resected sections, a fact that substantiates the effect
of H. pylori on these activities. The proliferative activities
detected in our gastritis sections were also significantly
higher in the presence of H. pylori while no such effect was
noticed on the apoptotic activities. Thus, the comparison
of these activities reveals that H. pylori infection increased
both the PI and AI in our GC sections, while it only
increased the PI in gastritis sections.
Several investigators have reported enhancement of
cell proliferation and apoptosis in the gastric epithelium
during H. pylori infection. Others failed, however, to
establish such a straightforward correlation, emphasizing
the importance of diversities of the strains.
In this study, the presence of cagA and the ABC-type
EPIYA motifs of H. pylori detected in gastric biopsies from
gastritis patients did not seem to affect the PI/AI ratio as
compared to H. pylori-negative biopsies. Further samples
from peptic ulcer and GC patients infected with H. pylori
that are cagA-positive with an increased number of the
EPIYA-C motifs are required to elaborate on the role of
these factors in these processes. Tiwari et al. (22) also
found no difference in AI in relation to the presence of
cagA.
We have found that the PI and the AI detected by the
TUNEL assay were lower than those detected by the CPP32
assay, regardless of the presence or absence of H. pylori.
This might be explained, as suggested earlier, by the fact
that immunohistochemical assay using CPP32 antibody
detects cells undergoing apoptosis at an early stage, before
DNA fragmentation, a late event in the apoptotic process
measured by the TUNEL assay. Thus, the CPP32 assay is
considered more sensitive and specific, and less dependent
on the observer’s subjective assessment.
Patients with IM are more likely to be at risk of
developing GC since it is implicated in the imbalance of
cell proliferation and apoptosis in the precancerous lesions.
Shinotami et al. (16) reported that the PI in the antrum
was significantly higher in GC patients with IM than in
the control group. Wambura et al. (32) compared the rates
of apoptosis and proliferation in mucosa with and without
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IM and demonstrated that, while antral apoptosis was
significantly lower in IM, proliferation was significantly
higher. We have also found that cell proliferation was
significantly associated with the presence of IM in
nontumor sites. This shows an agreement on the effect
of H. pylori on cell proliferation during the precancerous
stages, leading to an imbalance in cell kinetics. In addition,
the majority of IM cases detected in our sections were of
the complete type. In gastritis sections, infection with H.
pylori provoked more severe histopathological changes
and appeared to induce IM more so than in those without
the bacterium.
We have found that the majority of the GC types
detected in H. pylori-positive sections were of the
intestinal type, while in H. pylori-negative they were of the
diffuse type, emphasizing the important role of H. pylori
in this process. We detected no significant differences in
the staining of GC sections (intestinal type or diffuse type)
or gastritis sections for cell proliferation and apoptosis
in this study. Other investigators also reported no such
differences (27,28).
In conclusion, H. pylori infection increased the
proliferative and apoptotic activities in tumor and
nontumor sites of GC sections. The PI was significantly
higher in the tumor sites than in the nontumor sites,
regardless of H. pylori infection, while the AI was
significantly higher in both sites in the presence of H.
pylori. Cell proliferation, but not apoptosis, was found
to be significantly associated with IM in nontumor sites.
In gastritis sections a significantly higher PI than AI was
detected in the presence of H. pylori. Overall, the detection
of cell proliferation and apoptotic activities in tumor and
nontumor sites of each resected GC section provided
additional supportive evidence for the effect of H. pylori
on these activities.
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